Fluent Elara THC-CBD Blend Vape Cartridge – 300mg

$45.00

Balanced THC+CBD BlendElara is a blend of Cannabis sativa and Cannabis indica hybrid strains with an approximate 1:1 ratio of THC:CBD with only mild euphoria. Elara harmoniously blends the top characteristics of each strain into one product. Patients can benefit tremendously from the synergistic effects of THC + CBD in treating various types of medical conditions. Elara also contains a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.

Current medical literature supports the use of CBD+THC rich products for the treatment of all conditions approved for medical cannabis.

CBD Content: Approximately 50%

THC Content: Approximately 50%

THC to CBD Ratio: 1:1

Dosing Units: Each vaporizer 300 mg cartridge contains 1 mg CBD/THC inhalation

Total Doses: Approximately 300 inhalations per cartridge (1ml)

Sold By: Fluent

Categories: Vape Cartridges, CBD THC Balanced 1:1

Out of stock

Reviews

There are no reviews yet.

Be the first to review “Fluent Elara THC-CBD Blend Vape Cartridge – 300mg”

Your email address will not be published.

Product Description

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms. If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Cash & CanPay Accepted

Elara® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Elara®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.